Business Description
OncoSil Medical Ltd
ISIN : AU000000OSL3
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 45.72 | |||||
Equity-to-Asset | 0.63 | |||||
Debt-to-Equity | 0.03 | |||||
Debt-to-EBITDA | -0.01 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -6.24 | |||||
Beneish M-Score | -2.92 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -21.6 | |||||
3-Year EPS without NRI Growth Rate | -21.6 | |||||
3-Year FCF Growth Rate | -26 | |||||
3-Year Book Growth Rate | -37 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 48.61 | |||||
9-Day RSI | 50.74 | |||||
14-Day RSI | 49.4 | |||||
6-1 Month Momentum % | -41.18 | |||||
12-1 Month Momentum % | -55.88 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.74 | |||||
Quick Ratio | 2.74 | |||||
Cash Ratio | 2.14 | |||||
Days Sales Outstanding | 757.49 | |||||
Days Payable | 299.23 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -24.2 | |||||
Shareholder Yield % | -57.42 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | -683.26 | |||||
Operating Margin % | -5441 | |||||
Net Margin % | -4898.75 | |||||
FCF Margin % | -4297.91 | |||||
ROE % | -178.08 | |||||
ROA % | -137.57 | |||||
ROIC % | -2648.47 | |||||
ROC (Joel Greenblatt) % | -5607.69 | |||||
ROCE % | -187.05 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 2.5 | |||||
EV-to-EBIT | -0.96 | |||||
EV-to-EBITDA | -0.97 | |||||
EV-to-Revenue | 49.69 | |||||
EV-to-Forward-Revenue | 6.23 | |||||
EV-to-FCF | -1.16 | |||||
Earnings Yield (Greenblatt) % | -104.16 | |||||
FCF Yield % | -61.65 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
OncoSil Medical Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil A$) | 0.239 | ||
EPS (TTM) (A$) | -0.008 | ||
Beta | 1.36 | ||
Volatility % | 48.71 | ||
14-Day RSI | 49.4 | ||
14-Day ATR (A$) | 0.000567 | ||
20-Day SMA (A$) | 0.0048 | ||
12-1 Month Momentum % | -55.88 | ||
52-Week Range (A$) | 0.004 - 0.012277 | ||
Shares Outstanding (Mil) | 3,332.11 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
OncoSil Medical Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
OncoSil Medical Ltd Stock Events
Event | Date | Price(A$) | ||
---|---|---|---|---|
No Event Data |
OncoSil Medical Ltd Frequently Asked Questions
What is OncoSil Medical Ltd(ASX:OSL)'s stock price today?
When is next earnings date of OncoSil Medical Ltd(ASX:OSL)?
Does OncoSil Medical Ltd(ASX:OSL) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |